help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Böhm, J.
Right arrow Articles by Kosma, V.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Böhm, J.
Right arrow Articles by Kosma, V.-M.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 12 4806-4811
Copyright © 2000 by The Endocrine Society


Original Studies

Expression and Prognostic Value of {alpha}-, ß-, and {gamma}-Catenins in Differentiated Thyroid Carcinoma

Jan Böhm, Leo Niskanen, Kari Kiraly, Jari Kellokoski, Matti Eskelinen, Sinikka Hollmen, Esko Alhava and Veli-Matti Kosma

Department of Pathology and Forensic Medicine (J.B., K.K., J.K., V.-M.K.), University of Kuopio and Kuopio University Hospital, FIN-70211 Kuopio; and Departments of Medicine and Clinical Nutrition (L.N.), Otorhinolaryngology , Oral and Maxillofacial Unit (J.K.), and Surgery (M.E., E.A.), Kuopio University Hospital, FIN-70211 Kuopio; and Department of Pathology (S.H.), Satakunta Central Hospital, FIN-28500 Pori, Finland

Address correspondence and requests for reprints to: Veli-Matti Kosma, M.D., Ph.D., Department of Pathology and Forensic Medicine, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland. E-mail: VeliMatti.Kosma{at}uku.fi

Catenins ({alpha}, ß, and {gamma}) are a group of intracellular cell adhesion molecules that unite cytoskeleton with extracellular adhesion system. Abnormal expression of these molecules may have prognostic relevance in various carcinomas, including differentiated thyroid carcinoma (DTC). We have, therefore, evaluated the prognostic value of {alpha}-, ß-, and {gamma}-catenins along with traditional risk factors in 206 consecutive DTC patients by immunohistochemistry.

Papillary carcinomas showed normal staining pattern for {alpha}-, ß-, and {gamma}-catenins in 124 (60%), 136 (67%), and 94 (46%) cases, respectively. Follicular carcinomas expressed {alpha}-, ß-, and {gamma}-catenins normally in 16 (48%), 18 (55%), and 8 (32%) cases, respectively. Follicular type of tumor showed more often reduced staining for all catenins than papillary carcinoma (P = 0.009, P = 0.004, and P = 0.002, respectively). Age (>60 yr) and pTNM-stage were related to reduced {alpha}- and ß-catenin expression levels (P = 0.027 and P = 0.026, respectively) and larger size of the tumor to reduced ß- and {gamma}-catenin expressions (P = 0.039 and P = 0.007, respectively). Nodal metastases at the time of primary treatment related to reduced {alpha}-catenin expression and distal metastases to reduced ß- and {gamma}-catenin staining signals (P = 0.022, P = 0.014, and P = 0.039, respectively). Reduced {alpha}-catenin associated with tumor recurrence (P = 0.002) and reduced ß-catenin with cancer-related mortality (P = 0.005). The multivariate analysis for recurrence-free survival showed that {alpha}-catenin and serum thyroglobulin level 1 yr after primary treatment were prognostic of recurrent disease (hazards ratio, 3.42, P = 0.022; and hazards ratio, 10.03, P = 0.0001). In addition, {alpha}-catenin retained its prognostic significance in low-stage patients (P = 0.0151). We propose that the evaluation of {alpha}-catenin expression by immunohistochemistry in DTC patients has prognostic value in addition to that obtained by traditional prognostic factors.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
K A Voutilainen, M A Anttila, S M Sillanpaa, K M Ropponen, S V Saarikoski, M T Juhola, and V-M Kosma
Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer
J. Clin. Pathol., May 1, 2006; 59(5): 460 - 467.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Jarzab, M. Wiench, K. Fujarewicz, K. Simek, M. Jarzab, M. Oczko-Wojciechowska, J. Wloch, A. Czarniecka, E. Chmielik, D. Lange, et al.
Gene Expression Profile of Papillary Thyroid Cancer: Sources of Variability and Diagnostic Implications
Cancer Res., February 15, 2005; 65(4): 1587 - 1597.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society